PET-CT在乳腺癌诊断中的应用价值

黎海涛

PET-CT在乳腺癌诊断中的应用价值

黎海涛

文章导航 > 国际放射医学核医学杂志 > 2005, 29 > 5: (220-222)

引用本文:

Citation:

PET-CT在乳腺癌诊断中的应用价值

黎海涛

400038 重庆, 第三军医大学西南医院影像中心
中图分类号: R814.42;R817.4

The application value of PET-CT in the diagnosis of breast cancer

LI Hai-tao

Imaging Center, Southwestern Hospital, The Third Military Medical University, Chongqing 400038, China
CLC number: R814.42;R817.4

摘要: 乳腺癌是当今大多数国家妇女最常见的恶性肿瘤。在过去的数十年中,正电子发射体层显像(PET)的应用极大地提高了乳腺肿瘤的临床诊治率。然而由于PET对肿瘤病灶缺乏准确的解剖定位而使¹⁸F-氟代脱氧葡萄糖(¹⁸F-FDG) PET临床应用的准确性受到限制。PET-CT的完美结合使对肿瘤的解剖定位和诊断的敏感性及特异性得到了明显的提高。本文着重介绍PET-CT在乳腺癌治疗后再分期、疗效观察、术前分期和放疗计划拟定中的应用价值。
- 乳腺癌 /
- 正电子发射体层显像 /
- 计算机体层成像
Abstract: Breast cancer is the most common malignancy in women in most of countries. During the past decades, the application of PET with ¹⁸F-fluoro-2-deoxy-D-glocuse (¹⁸F-FDG) has remarkably improved the managemant of breast cancer. Nevertheless, due to anatomical localisation of ¹⁸F-FDG uptake was difficult, the clinical interpretation of ¹⁸F-FDG PET scan could not be exactly. A novel combined PET-CT system has largely improved the capacity of sensitivity and specificity in the diagnosis of breast cancer. In this artiacal we focus on the application value of PET-CT to breast cancer diagnosis, with respect to dissease re-staging, treatment monitoring, preoperative staging and radiotherapy planning.
- breast cancer /
- positron emission tomography /
- computed tomography
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Beyer T, Townsent DW, Brun T, et al. A combined PET-CT scanner for clinical oncology[J]. J Nucl Med, 2000, 41(8):1364-1374.
[2]	Townsend DW. A combined PET/CT scanner:the choices[J]. J Nucl Med, 2001, 42(3):533-534.
[3]	Goerres GW, Michel SC, Fehr MK, et al. Follow-up of women with breast cancer:comparison between MRI and FDG-PET[J]. Eur Radiol, 2003, 13(7):1635-1644.
[4]	Pelosi E, Messa C, Picchio M, et al. Value of integrated PET/CT for lesion localization in cancer patients:a comparative study[J]. Eur J Nucl Med Mol Imaging, 2004, 31(7):932-939.
[5]	Biersack HJ, Bender H, Palmedo H. FDG-PET in monitoring therapy of breast cancer[J]. Eur J Nucl Med Mol Imaging, 2004, 31(Suppl 1):S112-S117.
[6]	Biersack HJ, Palmedo H. Locally advanced breast cancer:is PET useful for monitoring primary chemotherapy?[J]. J Nucl Med, 2003,44(11):1815-1817.
[7]	Utech CI, Yong CS, Winter PF. Prospective evaluation of fluorine-18fluorodeoxyglucose positron emission tomography in breast cancer for staging the axilla related to surgery and immunocytochemistry[J].EurJ Nucl Med, 1996, 23(12):1588-1593.
[8]	Wahl RL, Siegel BA, Coleman RE, et al. Prospective multicenter study of axillary nodel staging by positron emission tomography in breast cancer:a report of the staging breast cancer with PET study group[J]. J Clin Oncol, 2004, 22(2):277-285.
[9]	Wang Y, Yu J, Liu J, et al. PET-CT in the diagnosis of both primary breast cancer and axillary lymph node metastasis:initial experience[J]. Int J Radiat Oncol Biol Phys, 2003, 57(Suppl):362-363.
[10]	Scheidhauer K, Scharl A, Pietrzyk U, et al. Qualitative[¹⁸F] FDG positron emission tomography in primary breast cancer:clinical relevance and practicability[J]. Eur J Nucl Med, 1996, 23(6):618-623.
[11]	Buck A, Schirrmeister H, Kuhn T, et al. FDG uptake in breast cancer:correlation with biological and clinical prognostic parameters[J].EurJ Nucl Med, 2002, 29(10):1317-1323.
[12]	Dizendorf EV. Impact of whole-body ¹⁸F-FDG PET on staging and managing patients for radiation therapy[J]. J Nucl Med, 2003, 44(1):24-29.
[13]	Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission tomography and computer tomography (PET/CT).:a feasibility study[J]. Int J Radiat Oncol Biol Phys, 2003, 57(3):853-863.

[1]	吴湖炳 . ¹⁸F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值. 国际放射医学核医学杂志, 2005, 29(5): 205-209.
[2]	陈璟 , 吴华 . 核素显像在乳腺癌诊治中的应用进展. 国际放射医学核医学杂志, 1998, 22(6): 252-255.
[3]	章斌 . ⁹⁹Tc^m-tetrofosmin在乳腺癌及其转移灶显像中的应用. 国际放射医学核医学杂志, 2001, 25(1): 12-15.
[4]	程兵 . ⁹⁹Tc^m-MIBI显像检测乳腺癌多药耐药. 国际放射医学核医学杂志, 2002, 26(2): 67-71.
[5]	陆汉魁 , 林祥通 , 刘家慧 , 林汉 . 乳腺癌和前列腺癌的类固醇受体显像研究现状. 国际放射医学核医学杂志, 1996, 20(3): 106-109.
[6]	王利伟 , 王自正 , 顾建平 , 王丽萍 , 王峰 . 孤立性肺结节的影像学研究进展. 国际放射医学核医学杂志, 2005, 29(6): 248-251.
[7]	季仲友 . PET-CT中诊断性CT的必要性与临床应用. 国际放射医学核医学杂志, 2005, 29(5): 197-200.
[8]	华逢春 , 管一晖 , 赵军 . ¹⁸F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用. 国际放射医学核医学杂志, 2005, 29(5): 216-219,226.
[9]	董孟杰 , 林祥通 , 赵军 . PET-CT在卵巢癌中的临床应用价值. 国际放射医学核医学杂志, 2005, 29(5): 209-213.
[10]	司宏伟 , 耿建华 , 陈盛祖 . PET-CT在调强适形放疗中的临床应用. 国际放射医学核医学杂志, 2005, 29(5): 223-226.
[11]	陈香 , 赵军 , 管一晖 . PET-CT常见伪影. 国际放射医学核医学杂志, 2005, 29(5): 201-205.

点击查看大图

计量

文章访问数: 1062
HTML全文浏览量: 79
PDF下载量: 3

PET-CT在乳腺癌诊断中的应用价值

黎海涛

400038 重庆, 第三军医大学西南医院影像中心

收稿日期: 2005-07-27

关键词:

摘要: 乳腺癌是当今大多数国家妇女最常见的恶性肿瘤。在过去的数十年中,正电子发射体层显像(PET)的应用极大地提高了乳腺肿瘤的临床诊治率。然而由于PET对肿瘤病灶缺乏准确的解剖定位而使¹⁸F-氟代脱氧葡萄糖(¹⁸F-FDG) PET临床应用的准确性受到限制。PET-CT的完美结合使对肿瘤的解剖定位和诊断的敏感性及特异性得到了明显的提高。本文着重介绍PET-CT在乳腺癌治疗后再分期、疗效观察、术前分期和放疗计划拟定中的应用价值。